Edinburgh (Scotland) experience with Rh immunoglobulin.
D000917:Antibody Formation; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005260:Female; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins